Skip to Content

Duloxetine Boehringer Ingelheim

Active Substance: duloxetine
Common Name: duloxetine
ATC Code: N06AX21
Marketing Authorisation Holder: Boehringer Ingelheim International GmbH
Active Substance: duloxetine
Status: Withdrawn
Authorisation Date: 2008-10-08
Therapeutic Area: Diabetic Neuropathies
Pharmacotherapeutic Group: Psychoanaleptics

Therapeutic Indication

Treatment of diabetic peripheral neuropathic pain in adults.

The marketing authorisation for Duloxetine Boehringer Ingelheim has been withdrawn at the request of the marketing-authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.